Drawing for CIRIGO

USPTO serial 79192439

CIRIGO

Reviewed by CopyMark Law Group

Reg. 5211371Status 404
Filing date
Status date
Registration date
May 30, 2017
Examiner
BROWN, TINA
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CIRIGO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maury M. Tepper, III

Maury M. Tepper, III Tepper & Eyster, PLLC3724 Benson DriveRaleigh, NC 27609UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; anti-fungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthmaSECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 21, 2023DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Aug 21, 2023DETHDEATH OF INTERNATIONAL REGISTRATION—
Mar 6, 2021GPNXNOTIFICATION PROCESSED BY IB—
Oct 24, 2020GPNXNOTIFICATION PROCESSED BY IB—
Jun 26, 2020DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Jun 26, 2020DETHDEATH OF INTERNATIONAL REGISTRATION—
Oct 20, 2017FINVFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 6, 2017FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 6, 2017FIMPFINAL DISPOSITION PROCESSED—
Aug 30, 2017FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 30, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 14, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 14, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 10, 2017GPNXNOTIFICATION PROCESSED BY IB—
Feb 22, 2017OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 22, 2017OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Feb 22, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 3, 2017PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 19, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 18, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 18, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 11, 2017ALIEASSIGNED TO LIE—
Dec 12, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 1, 2016ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 1, 2016REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 25, 2016RFNTREFUSAL PROCESSED BY IB—
Nov 9, 2016RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 9, 2016RFRRREFUSAL PROCESSED BY MPU—
Oct 15, 2016RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 14, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 13, 2016DOCKASSIGNED TO EXAMINER—
Oct 11, 2016MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 6, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 30, 2016LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Sep 22, 2016SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance